Cite
Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies.
MLA
Alnuqaydan, Abdullah M., et al. “Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies.” AAPS PharmSciTech, vol. 22, no. 5, July 2021, pp. 1–23. EBSCOhost, https://doi.org/10.1208/s12249-021-02062-2.
APA
Alnuqaydan, A. M., Almutary, A. G., Sukamaran, A., Yang, B. T. W., Lee, X. T., Lim, W. X., Ng, Y. M., Ibrahim, R., Darmarajan, T., Nanjappan, S., Chellian, J., Candasamy, M., Madheswaran, T., Sharma, A., Dureja, H., Prasher, P., Verma, N., Kumar, D., Palaniveloo, K., & Bisht, D. (2021). Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech, 22(5), 1–23. https://doi.org/10.1208/s12249-021-02062-2
Chicago
Alnuqaydan, Abdullah M, Abdulmajeed G Almutary, Arulmalar Sukamaran, Brian Tay Wei Yang, Xiao Ting Lee, Wei Xuan Lim, Yee Min Ng, et al. 2021. “Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies.” AAPS PharmSciTech 22 (5): 1–23. doi:10.1208/s12249-021-02062-2.